CEACAM5 and ovarian carcinoma: Another vaccine strain utilizing measles virus engineered to express carcinoembryonic antigen (MV-CEA virus) was investigated in a Phase I study of patients with platinum resistance ovarian cancer who have normal CEA levels 87.